Abstract
Ménétrier’s disease (MD) is characterized by enlargement of gastric mucosal folds that most often involve the fundus. The cause of MD is unknown. Gastric cancer is the mostly reported association of Ménétrier’s disease. We present the first case of a patient having colonic adenocarcinoma and also Ménétrier’s disease.
Résumé
La maladie de Ménétrier est caractérisée par l’élargissement des rides de la muqueuse gastrique avec, le plus souvent, atteinte du fond. La cause de la maladie de Ménétrier est inconnue. L’association la plus communément rapportée de la maladie de Ménétrier est le cancer g astrique. Nous rapportons un premier cas d’un patient présentant un adénocarcinome du côlon et également la maladie de Ménétrier.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sferra TJ, Pawel BR, Qualman SJ, Li B U. Ménétrier disease of childhood: role of cytomeg alovirus and transforming growth factor alpha. J Pediatr 1996;128:213–219.
Kawasaki M, Hizawa K, Aoyagi K, Nakamura S, Fujishima M. Ménétrier’s disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. Am J Gastroenterol 1997;92:1909–1912.
Stamm B. Localized hyperplastic gastropathy of the mucous cell- and mixed cell-type (localized Ménétrier’s disease): a report of 11 patients. Am J Surg Pathol 1997;21:1334–1342.
Coffey RJ, Romano M, Polk WH, Dempsey PJ. Roles for transforming growth factor-alpha in gastric physiology and pathophysiology. Yale J Biol Med 1992;65:693–704.
Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003;21:2787–2799.
Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transacti vates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289–293.
Desreumaux P. Central role of epidermic growth factor receptor (EGFR) in hypertrophic gastropathy and cancer of the colon. Gastroenterol Clin Biol 2002;26:648–649.
Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, et al. Treatment of Ménétrier’s disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med 2000;343:1697–1701.
Settle SH, Washington K, Lind C, Itzkowitz S, Fiske WH, Burdick JS, et al. Chronic treatment of Ménétrier’s disease with Erbitux: clinical efficacy and insight into pathophysiology. Clin Gastroenterol Hepatol 2005;3:654–659.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Köklü, S., Arhan, M., Tas, A. et al. An unusual association of Ménétrier’s disease and colon cancer. Acta Endosc 39, 434–436 (2009). https://doi.org/10.1007/s10190-009-0115-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-009-0115-y